Development of a new molecular target for glioma mediated ribosome synthesis inhibition (nucleolar stress)
Project/Area Number |
26861164
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Neurosurgery
|
Research Institution | Keio University |
Principal Investigator |
MIWA TOMORU 慶應義塾大学, 医学部, 助教 (20365282)
|
Project Period (FY) |
2014-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | EFTUD1 / glioma / ribosome / western blot / glioma cell line / Western blot |
Outline of Final Research Achievements |
EFTUD1 expression in glioma cell lines and tissue was higher than in normal brain tissue. Downregulating EFTUD1 induced G1 cell-cycle arrest and apoptosis, leading to reduced glioma cell proliferation. The mechanism underlying this antitumor effect was impaired ribosome biogenesis via EFTUD1 inhibition. Additionally, protective autophagy was induced by glioma cells as an adaptive response to EFTUD1 inhibition. The antitumor effect induced by the combined treatment was significantly higher than that of either EFTUD1 inhibition or CQ alone. These results suggest that EFTUD1 represents a novel therapeutic target and that the combination of EFTUD1 inhibition with autophagy blockade may be effective in the treatment of gliomas.
|
Report
(3 results)
Research Products
(8 results)
-
-
-
-
[Presentation] 線維性骨異形成症手術例の検討2015
Author(s)
三輪点 坂本好昭 大平貴之 貴志和生 吉田一成
Organizer
日本脳神経外科学会第74回学術総会
Place of Presentation
ロイトン札幌 (北海道札幌市)
Year and Date
2015-10-16
Related Report
-
-
-
-